Antiosteoporotic Activity of Genistein Aglycone in Postmenopausal Women: Evidence from a Post-Hoc Analysis of a Multicenter Randomized Controlled Trial

Genistein effects on quality of life and depression symptoms in osteopenic postmenopausal women: a 2-year randomized, double-blind, controlled study

(2013) M. Atteritano et al.   OSTEOPOROSIS INTERNATIONAL

Genistein Aglycone: A Dual Mode of Action Anti-Osteoporotic Soy Isoflavone Rebalancing Bone Turnover Towards Bone Formation

(2010) A. Bitto et al.   CURRENT MEDICINAL CHEMISTRY

Genistein aglycone reverses glucocorticoid-induced osteoporosis and increases bone breaking strength in rats: a comparative study with alendronate

(2009) A Bitto et al.   BRITISH JOURNAL OF PHARMACOLOGY

Genistein effects on quantitative ultrasound parameters and bone mineral density in osteopenic postmenopausal women

(2009) M. Atteritano et al.   OSTEOPOROSIS INTERNATIONAL

Evaluation of bone quality and quantity in osteoporotic mice – The effects of genistein and equol

(2009) S. Sehmisch et al.   PHYTOMEDICINE

Effects of phytoestrogen genistein on cytogenetic biomarkers in postmenopausal women: 1 year randomized, placebo-controlled study

(2008) Marco Atteritano et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

OPG and sRANKL Serum Concentrations in Osteopenic, Postmenopausal Women After 2-Year Genistein Administration

(2008) Herbert Marini et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Breast Safety and Efficacy of Genistein Aglycone for Postmenopausal Bone Loss: A Follow-Up Study

(2008) Herbert Marini et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

European guidance for the diagnosis and management of osteoporosis in postmenopausal women

(2008) J. A. Kanis et al.   OSTEOPOROSIS INTERNATIONAL

FRAX™ and the assessment of fracture probability in men and women from the UK

(2008) J. A. Kanis et al.   OSTEOPOROSIS INTERNATIONAL

Advances in hormone replacement therapy: making the menopause manageable

(2008) Santiago Palacios   BMC Womens Health